Nox Connect™ unveils the next generation of conclusive, connected sleep care at SLEEP 2025
Nox Medical is proud to unveil the expanded capabilities of Nox Connect™, a secure, cloud-based platform that now features Artificial Intelligence, web-based scoring and interpretation, and a fully integrated Home Sleep Testing Service. The new platform features will be showcased at the SLEEP 2025 conference in Seattle, offering a glimpse into the future of connected, intelligent sleep diagnostics.
“Nox Connect is now the backbone of our diagnostic portfolio,” said Hulda Hallgrimsdottir, COO at Nox Medical “it unifies secure data management and AI-assisted scoring and interpretation into a unified platform—simplifying workflows across in-lab and home testing, and enabling clinicians to interpret studies with clarity and efficiency from anywhere”.
Built on the highest security standards, Nox Connect enables sleep labs and health systems to manage diagnostics, testing logistics, and scoring workflows—from anywhere. At the heart of the platform is a range of FDA-cleared AI tools that support clinical decision-making, including BodySleepTM, OSA Endotyping, Hypoxic Burden, and Ventilatory Burden as part of Noxturnal Web*.
“For nearly two decades, Nox has been at the forefront of diagnostic innovation—delivering technology recognized for its accuracy, precision, and patient-friendly design,”
said Sveinbjörn Höskuldsson, Founder and CTO at Nox Medical. With the launch of Nox Connect, that legacy continues—now extended to the cloud with intelligent tools like Nox BodySleep™, which give clinicians greater clarity in interpreting home sleep tests by capturing arousals and sleep staging through respiratory signals. These insights support more conclusive interpretations often missed by proxy-based HSATs.
“Unlike proxy-based systems that rely on indirect signals, Nox devices are built on calibrated RIP—Nox Flow™, delivering real, quantifiable airflow and effort data for every patient, in every setting. This foundational technology supports diagnostic accuracy across a broad spectrum of patients and care environments.”
This same clinical rigor now powers the newly launched Nox Home Sleep Testing Service—an end-to-end solution built on the trusted Nox T3® HSAT device and enhanced by Nox BodySleep. Fully integrated with Nox Connect, the service allows providers to easily order tests, manage logistics, and receive AI-scored results directly in the cloud. It’s a powerful way to expand access to high-quality diagnostics without requiring device ownership or added infrastructure.
Every patient deserves an accurate sleep diagnosis—regardless of where the test takes place,” said Dr. Heidi Riney, Chief Medical Officer. “Nox delivers on that promise with real respiratory flow measurement, validated AI insights, and scalable cloud access tailored to modern clinical and operational needs.
What’s New in Nox Connect:
- AI Scoring & Insights: Access FDA-cleared tools like Nox BodySleep™, Ventilatory Burden, Hypoxic Burden, and OSA Endotyping— available in the cloud to support diagnostic clarity and personalized care.
- Nox BodySleep™: Unlocks conclusive home sleep testing by detecting sleep stages and arousals directly from respiratory signals.
- Ventilatory Burden and Hypoxic Burden: Provide advanced insights into patient risk and disease severity beyond AHI.
- OSA Endotyping: Supports personalized therapy decisions by identifying physiological drivers of sleep-disordered breathing.
- Web-Based Scoring: Score and review studies directly in the browser for seamless collaboration and remote workflows*.
- Home Sleep Testing Service: Cloud-based HSAT logistics with test ordering, kit delivery, Nox AI scoring, and data handover managed through Nox Connect—no in-house devices required.
- Cloud Collaboration: Assign, track, and review tasks across teams. Scorers, technologists, and physicians can collaborate securely.
- Secure, Scalable Infrastructure: Built in a secure and compliant cloud with HIPAA, HITRUST, ISO 27001, SOC 1 & 2 certifications.
Nox Connect will be demonstrated at Booth #617 at SLEEP 2025 in Seattle, WA, and will be available to sleep labs, health systems, and home testing programs following the conference.
*Noxturnal Web is a medical device cleared for clinical use by the FDA
Topic: Company Updates
